Young Wendy B.

Young Wendy B. is listed in filings as Director at Adial Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 16, 2026, including purchase activity. Recent filings connect the profile to Adial Pharmaceuticals, Inc. (ADIL) and Rapport Therapeutics, Inc. Common Stock (RAPP). The current snapshot covers public activity from Nov 7, 2024 to Jun 16, 2026. Reported amounts are shown as $36 to $61.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.